New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report
Biolex Releases Locteron(R) Phase IIa Trial Results II-54
Schering-Plough Releases Details of Boceprevir Phase II Study II-54
Releases Pre-Clinical Results of PRO 206 II-55
ZymoGenetics Reveals Phase Ib Results of IL-29 II-55
Phenomix Begins Phase Ia Study of PHX1766 ...
Drug developed at the University of Chicago wins FDA approval
...often limit how aggressive we can be."
In 2001, progenics
Pharmaceuticals, Inc., of Tarrytown, NY, bought th... from the University of Chicago. In December 2005, progenics
entered into an exclusive, worldwide agreement wit...Moss and Yuan continue to serve as consultants for progenics
This unusual drug inspired several unusual clin...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
...) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion Corp. (Nasdaq: PHRM ) progenics
Pharmaceuticals Inc. (Nasdaq: PGNX ) Regeneron Pharmaceuticals (Nasdaq: REGN ) Respironics Inc. (Nasdaq: RESP ) Sepracor Inc. (Nasdaq: SEPR ...
Progenics in Medical Technology
Wyeth and Progenics Announce Preliminary Clinical Trial Results for RELISTOR Oral and Intravenous Formulations
COLLEGEVILLE, Pa., and TARRYTOWN, N.Y., May 22 /PRNewswire/ -- Wyeth
Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Progenics
Pharmaceuticals, Inc. (Nasdaq: PGNX ), today announced preliminary results
from two clinical trials conducted with investigational oral and
Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials
Trofile to be used to screen patients for clinical program of monoclonal antibody to CCR5
SOUTH SAN FRANCISCO, Calif., April 1, 2008 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc., (Nasdaq: MGRM ) announced today that it had
entered into an agreement with Prog...
New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
...w information, future
developments or otherwise.
Pharmaceuticals, Inc., of Tarrytown, NY, is a
on the surface of prostate cancer cells. progenics
is also developing
vaccines designed to stimulate an immune response to PSMA.
DISCLOSURE NOTICE: The information contained in th...
Seattle Genetics Highlights Data on its Proprietary Antibody-Drug
Conjugate Technology at AACR
...cs has collaborations for its ADC technology with a number of
leading biotechnology and pharmaceutical companies, including
Genentech, Bayer, CuraGen, progenics
and MedImmune, as well as an
ADC co-development agreement with Agensys. More information can be
found at www.seattlegenetics.com.
Certain of the sta...
Progenics Announces Positive Results in Clinical Trial of Novel HIV
...in HIV infection represent
a major achievement for progenics
and a further strengthening of
our drug pipeline,"...e cells towards sites of inflammation in the
and its collaborators discovered the role of CCR5
...nditions. With Fast Track designation for PRO
can take advantage of several programs at FDA to
Progenics and Wyeth Announce Positive Results from Three-Month
Clinical-Extension Study of Subcutaneous Methylnaltrexone for the
Treatment of Opioid-Induced Constipation in Patients with Advanced
...mp; MADISON, N.J.--(BUSINESS WIRE)--Jun 28, 2007
Pharmaceuticals, Inc. (NASDAQ: PGNX) and Wyeth
About the Companies
Pharmaceuticals, Inc., of Tarrytown, N.Y., is a
bi...ein found on the
surface of prostate cancer cells. progenics
also is developing
vaccines designed to stimulate ...
Progenics in Medical Dictionary
.... Continuous Subcutaneous Infusion of Opiates at End-of-Life. Ann. Pharmacother. ... Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and progenics
Pharmaceuticals, Inc. ... RELISTOR subcutaneous injection is approved in the United ... ...
Progenics in Biological Technology
Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
Final Decision from European Commission Expected by Mid-2008
COLLEGEVILLE, Pa. and TARRYTOWN, N.Y., April 24 /PRNewswire-FirstCall/
-- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Progenics
Pharmaceuticals, Inc. (Nasdaq: PGNX ), today announced that the companies
Core Informatics Completes Successful LIMS Implementation for Progenics Pharmaceuticals
BRANFORD, Conn., March 27 /PRNewswire/ -- Core Informatics announces
that it has completed a successful implementation of their web-based
Laboratory Information Management System (LIMS) product, the "Core LIMS",
Pharmaceuticals Inc. (Nasdaq: PGNX ), a biopharmaceutical
New Report Just Published: World Prostate Cancer Therapeutics Market Report
...maceuticals, Inc., Paladin Labs Inc., Pfizer Inc., progenics
Pharmaceuticals, Inc., Sanofi-Aventis SA, Spectrum...Enters into Agreement with Nippon Kayaku II-79
Pharmaceuticals Broadens Association with Seattle
...gy Expands Antigen Express Cancer Trials II-80
Pharmaceuticals Acquires PSMA Development Company ...
Savient Announces Appointment of David Gionco as Chief Financial Officer
...it, corporate accounting, financial planning, finance and controller roles of increasing responsibility at companies including Medco, Merck & Co., progenics
Pharmaceuticals and Odyssey Pharmaceuticals, where he served as Acting Chief Financial Officer/Director of Finance and Controller before joining Savie...
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
... TECHNOLOGIES CORP (NASDAQ: DVAX ) GPC BIOTECH AG-ADR (NASDAQ: GPCB ) IMMUNOGEN INC. (NASDAQ: IMGN ) PEREGRINE PHARMACEUTICALS (NASDAQ: PPHM ) progenics
PHARMACEUTICALS (NASDAQ: PGNX ) TELIK INC. (NASDAQ: TELK ) XOMA LTD (NASDAQ: XOMA )
ANTISOMA (London Main Market, U.K.: ASM) ARDEA BIOSC...
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
... MRX ) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion Corp. (Nasdaq: PHRM ) progenics
Pharmaceuticals Inc. (Nasdaq: PGNX ) Regeneron Pharmaceuticals (Nasdaq: REGN ) Respironics Inc. (Nasdaq: RESP ) Sepracor Inc. (Nasdaq: SEPR ) ...
Progenics in Biological Dictionary
...hem become more sustainable or " ... Home. About Us. Directors. Management Team. Services. Market ... © 2009 Calyx Securities Limited. Powered by progenics
Corp Limited. All rights reserved. ... The North Face Calyx - Women's. The stylish Calyx handbag is designed and styled by The North Face for t...